# Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older

> **NCT06678607** · PHASE1 · COMPLETED · sponsor: **Shanghai Reinovax Biologics Co.,LTD** · enrollment: 240 (actual)

## Conditions studied

- Pneumococcal Infectious Disease

## Interventions

- **BIOLOGICAL:** Reinovax PCV24 formulation 1
- **BIOLOGICAL:** Reinovax PCV24 formulation 2
- **BIOLOGICAL:** PPSV23
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06678607
- **Lead sponsor:** Shanghai Reinovax Biologics Co.,LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-19
- **Primary completion:** 2024-07-28
- **Final completion:** 2024-07-28
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06678607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06678607, "Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06678607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*